CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Grant or award Chief Executive Officer acquired 18,677 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 27,602 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,893 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 5,714 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 5,324 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 3,378 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 153,550 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,671 shares (grant or award)
- 4 Grant or award Director acquired 19,000 shares (grant or award)
- 4 Grant or award Director acquired 19,000 shares (grant or award)
- 4 Grant or award Director acquired 19,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 64,609 shares (grant or award)
- 4 Grant or award President acquired 64,609 shares (grant or award)
- 4 Grant or award Director acquired 19,000 shares (grant or award)
- 4 Grant or award Director acquired 19,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 96,913 shares (grant or award)
- 4 Grant or award Director acquired 19,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,159 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 2,578 shares (grant or award)
- 4 Open-market buy President bought 2,000 shares at $1.57 ($3,140)
Page 1 of 14 · 261 filings